# ASCT for Relapsed APL After Molecular Remission

> **NCT00907582** · PHASE2 · TERMINATED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 5 (actual)

## Conditions studied

- Acute Promyelocytic Leukemia
- Relapse

## Interventions

- **PROCEDURE:** autologous hematopoietic cell transplantation

## Key facts

- **NCT ID:** NCT00907582
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** slow recruitment
- **Last updated:** 2014-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00907582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00907582, "ASCT for Relapsed APL After Molecular Remission". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00907582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*